On November 29, 2018, FDA issued a safety announcement warning that multiple sclerosis drug Lemtrada has been linked to cases of stroke and tears in the lining of the arteries in the head and neck. These serious injuries can lead to permanent disability and death. Given the nature of these risks, FDA has announced that the warning label for Lemtrada will be changed to include these risks.
Read the FDA Announcement: FDA Drug Safety Announcement
Lemtrada is used to treat individuals with relapsing forms of Multiple Sclerosis and is administered through an IV infusion. Since Lemtrada was approved for use in the United States in 2014, FDA has received multiple reports of individuals suffering ischemic and hemorrhagic stroke or arterial dissection occurring shortly after they received Lemtrada. One of these individuals died from their injuries.
If you or a loved one have suffered a stroke or tear in the artery lining shortly after receiving Lemtrada, contact one of the experienced defective drug attorneys at Burg Simpson today to discuss your legal rights. Our award-winning attorneys would be happy yo discuss your potential claim.
While Burg Simpson has a broad range of expertise, the Ohio office has a wealth of experience in the following practices:
CONSUMER PRODUCT LIABILITY
DEFECTIVE DRUGS & MEDICAL DEVICES
MOTOR VEHICLE ACCIDENTS
WHISTLEBLOWER/QUI TAM ACTIONS
WRONGFUL DEATH/CATASTROPHIC INJURY
Burg Simpson has seven offices in six states, and we represent clients nationwide.
Our Ohio office, established in 2007, is situated in the heart of the Cincinnati Central Business District, just across the street from the Great American Ball Park.
Call us at 1-800-713-9340 or fill out our contact form for a FREE no-obligation consultation today.